Advertisement
Correspondence

Authors' Reply

  • Erick Turner mail,

    turnere@ohsu.edu

    Affiliation: Portland VA Medical Center and Oregon Health and Science University, Portland, Oregon, United States of America

    X
  • Martin Tramèr

    Affiliation: Geneva University Hospitals, Geneva, Switzerland

    X
  • Published: June 28, 2005
  • DOI: 10.1371/journal.pmed.0020187

About the Authors

Erick Turner
Portland VA Medical Center and Oregon Health and Science University, Portland, Oregon, United States of America
Martin Tramèr
Geneva University Hospitals, Geneva, Switzerland

Corresponding Author

Email: turnere@ohsu.edu

Competing Interests

EHT is on the speaker's bureaus of Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. He has provided outside consulting to Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, and Sepracor. He has also received funding for clinical drug trials, which can be spent only for research purposes and which has no effect on his income, from Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, and DOV Pharmaceuticals. MRT has been a scientific consultant to Pfizer, Merck, Janssen-Cilag, and Sintetica. He has also received lecture fees from various pharmaceutical companies.